Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

By Biswajyoti Sahu, M. Laakso, K. Ovaska, T. Mirtti, J. Lundin, A. Rannikko, A. Sankila, J. Turunen, M. Lundin, Juho Konsti and 5 more. 2011

400 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Impact of cytosine methylation on DNA binding specificities of human transcription factors (2017, methodology): “The chromatin immunoprecipitation (ChIP) was performed as previously described withminor modifications (70) by using antibodies for OCT4, KLF4, n-Myc (Abcam cat.”
Comprehensive molecular portraits of invasive lobular breast cancer (2015, background): “High FOXA1 expression has been previously reported in breast and prostate cancer (Habashy et al., 2008; Sahu et al., 2011) and somatic mutations in the FOXA1 gene have been reported in these tumor types in about 3%–4% of the cases (Barbieri et al., 2012; Cancer Genome Atlas, 2012; Robinson et al.,…”